Matthew DeBerge

1.7k total citations
32 papers, 1.2k citations indexed

About

Matthew DeBerge is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Matthew DeBerge has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Matthew DeBerge's work include Immune cells in cancer (12 papers), Phagocytosis and Immune Regulation (11 papers) and Cardiac Fibrosis and Remodeling (8 papers). Matthew DeBerge is often cited by papers focused on Immune cells in cancer (12 papers), Phagocytosis and Immune Regulation (11 papers) and Cardiac Fibrosis and Remodeling (8 papers). Matthew DeBerge collaborates with scholars based in United States, France and Philippines. Matthew DeBerge's co-authors include Edward B. Thorp, Shuang Zhang, Lisa D. Wilsbacher, Richard I. Enelow, Laurent Yvan‐Charvet, Navdeep S. Chandel, Paul T. Schumacker, Samuel E. Weinberg, Jason M. Kinchen and Issam Ben‐Sahra and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Matthew DeBerge

31 papers receiving 1.2k citations

Peers

Matthew DeBerge

IMMUN

CCM

SURGE

EPIDE

Laurent Burnier Switzerland

Mark Kelly United States

Suzhao Li United States

Janet Chamberlain United Kingdom

Joachim Pircher Germany

Deya Cherpokova United States

G Franck France

Joel D. Schilling United States

Anna‐Pia Papageorgiou Belgium

Hiroshi Koriyama Japan

Laurent Burnier Switzerland

Matthew DeBerge

394 ×0.6

IMMUN

475 ×1.2

163 ×0.5

CCM

161 ×0.9

SURGE

72 ×0.4

EPIDE

Citations per year, relative to Matthew DeBerge Matthew DeBerge (= 1×) peers Laurent Burnier

Countries citing papers authored by Matthew DeBerge

Since Specialization

Citations

This map shows the geographic impact of Matthew DeBerge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew DeBerge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew DeBerge more than expected).

Fields of papers citing papers by Matthew DeBerge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew DeBerge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew DeBerge. The network helps show where Matthew DeBerge may publish in the future.

Co-authorship network of co-authors of Matthew DeBerge

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew DeBerge. A scholar is included among the top collaborators of Matthew DeBerge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew DeBerge. Matthew DeBerge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

DeBerge, Matthew, Connor Lantz, Zhi‐Dong Ge, et al.. (2025). Mechanical regulation of macrophage metabolism by allograft inflammatory factor 1 leads to adverse remodeling after cardiac injury. Nature Cardiovascular Research. 4(1). 83–101. 3 indexed citations

Ge, Zhi‐Dong, Matthew DeBerge, Connor Lantz, et al.. (2025). Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction. Circulation. 151(20). 1451–1466. 6 indexed citations

Lantz, Connor, Matthew DeBerge, A Ananthakrishnan, et al.. (2025). Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration. Immunity. 58(2). 344–361.e7. 5 indexed citations

Thorp, Edward B., et al.. (2024). CCR2+ monocytes promote white matter injury and cognitive dysfunction after myocardial infarction. Brain Behavior and Immunity. 119. 818–835. 6 indexed citations

DeBerge, Matthew, Fanfan Du, Jiao‐Jing Wang, et al.. (2024). Hypoxia inducible factor 2α promotes tolerogenic macrophage development during cardiac transplantation through transcriptional regulation of colony stimulating factor 1 receptor. Proceedings of the National Academy of Sciences. 121(26). e2319623121–e2319623121. 2 indexed citations

DeBerge, Matthew, et al.. (2023). Immunometabolism at the Heart of Cardiovascular Disease. JACC Basic to Translational Science. 8(7). 884–904. 30 indexed citations

Thorp, Edward B., Margaret E. Flanagan, Brian Popko, & Matthew DeBerge. (2022). Resolving inflammatory links between myocardial infarction and vascular dementia. Seminars in Immunology. 59. 101600–101600. 10 indexed citations

DeBerge, Matthew, Arjun Sinha, Jiao-Jing Wang, et al.. (2021). Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 40(6). 435–446. 6 indexed citations

Sinha, Arjun, Adovich S. Rivera, Anna Pawlowski, et al.. (2021). Comparative Risk of Incident Coronary Heart Disease Across Chronic Inflammatory Diseases. Frontiers in Cardiovascular Medicine. 8. 757738–757738. 6 indexed citations

10.

DeBerge, Matthew, Manikandan Subramanian, Lisa D. Wilsbacher, et al.. (2021). Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction. Journal of Clinical Investigation. 131(6). 72 indexed citations

11.

DeBerge, Matthew, Connor Lantz, Shirley Dehn, et al.. (2021). Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair. The Journal of Experimental Medicine. 218(9). 47 indexed citations

12.

DeBerge, Matthew, Sanjiv J. Shah, Lisa D. Wilsbacher, & Edward B. Thorp. (2019). Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction. Trends in Molecular Medicine. 25(4). 328–340. 81 indexed citations

13.

Zhang, Shuang, Samuel E. Weinberg, Matthew DeBerge, et al.. (2018). Efferocytosis Fuels Requirements of Fatty Acid Oxidation and the Electron Transport Chain to Polarize Macrophages for Tissue Repair. Cell Metabolism. 29(2). 443–456.e5. 319 indexed citations

14.

DeBerge, Matthew, et al.. (2018). Acute and chronic phagocyte determinants of cardiac allograft vasculopathy. Seminars in Immunopathology. 40(6). 593–603. 5 indexed citations

15.

Zhang, Shuang, Matthew DeBerge, Kevin Wang, et al.. (2017). Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair. JACC Basic to Translational Science. 2(4). 386–397. 44 indexed citations

16.

Dehn, Shirley, Matthew DeBerge, Laurent Yvan‐Charvet, et al.. (2016). HIF-2α in Resting Macrophages Tempers Mitochondrial Reactive Oxygen Species To Selectively Repress MARCO-Dependent Phagocytosis. The Journal of Immunology. 197(9). 3639–3649. 26 indexed citations

17.

Zhang, Shuang, Lubov Grigoryeva, Shirley Dehn, et al.. (2015). Cardiomyocytes induce macrophage receptor shedding to suppress phagocytosis. Journal of Molecular and Cellular Cardiology. 87. 171–179. 28 indexed citations

18.

Zhang, Shuang, Shirley Dehn, Matthew DeBerge, et al.. (2014). Phagocyte–myocyte interactions and consequences during hypoxic wound healing. Cellular Immunology. 291(1-2). 65–73. 14 indexed citations

19.

Ely, Kenneth H., Matthew DeBerge, Jun Liu, et al.. (2014). Tissue-Protective Effects of NKG2A in Immune-Mediated Clearance of Virus Infection. PLoS ONE. 9(9). e108385–e108385. 12 indexed citations

20.

DeBerge, Matthew, Kenneth H. Ely, Guang‐Shing Cheng, & Richard I. Enelow. (2013). ADAM17-Mediated Processing of TNF-α Expressed by Antiviral Effector CD8+ T Cells Is Required for Severe T-Cell-Mediated Lung Injury. PLoS ONE. 8(11). e79340–e79340. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact